Chris Howerton
Stock Analyst at Jefferies
(3.27)
# 1,127
Out of 4,479 analysts
53
Total ratings
43.86%
Success rate
15.97%
Average return
Main Sectors:
Top Industries:
31 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GPCR Structure Therapeutics | Maintains: Buy | $50 → $79 | $38.73 | +103.98% | 2 | Sep 29, 2023 | |
| MIST Milestone Pharmaceuticals | Downgrades: Hold | $8 → $4 | $1.35 | +196.30% | 3 | Jun 20, 2023 | |
| VERU Veru Inc. | Upgrades: Hold | $1 | $0.95 | +4.87% | 3 | Jun 7, 2023 | |
| BTAI BioXcel Therapeutics | Downgrades: Hold | $20 → $22 | $1.12 | +1,864.29% | 2 | Mar 10, 2023 | |
| AVTX Avalo Therapeutics | Downgrades: Underperform | $720 | $12.26 | +5,772.76% | 2 | Feb 8, 2023 | |
| CGEN Compugen | Downgrades: Underperform | $0.5 | $1.69 | -70.41% | 2 | Feb 8, 2023 | |
| URGN UroGen Pharma | Downgrades: Hold | $35 → $10 | $15.14 | -33.95% | 1 | Feb 8, 2023 | |
| MEIP MEI Pharma | Downgrades: Underperform | $8 → $2 | $2.80 | -28.57% | 3 | Feb 8, 2023 | |
| AVDL Avadel Pharmaceuticals | Upgrades: Buy | $6.5 → $11 | $13.89 | -20.81% | 3 | Nov 30, 2022 | |
| APLS Apellis Pharmaceuticals | Downgrades: Hold | $70 → $40 | $34.98 | +14.35% | 2 | Nov 10, 2022 | |
| HRMY Harmony Biosciences Holdings | Upgrades: Buy | $57 → $61 | $30.00 | +103.33% | 3 | Oct 14, 2022 | |
| AXSM Axsome Therapeutics | Maintains: Buy | $92 → $90 | $78.93 | +14.03% | 3 | Sep 30, 2022 | |
| FNCH Finch Therapeutics Group | Maintains: Buy | $870 → $510 | $1.37 | +37,126.28% | 2 | Apr 4, 2022 | |
| ARDX Ardelyx | Upgrades: Buy | $1 → $5 | $5.28 | -5.30% | 3 | Mar 2, 2022 | |
| VNDA Vanda Pharmaceuticals | Downgrades: Hold | $24 → $12 | $5.27 | +127.70% | 1 | Feb 25, 2022 | |
| IGMS IGM Biosciences | Maintains: Buy | n/a | $6.40 | - | 1 | Dec 13, 2021 | |
| IOBT IO Biotech | Initiates: Buy | n/a | $1.18 | - | 1 | Nov 30, 2021 | |
| CLDX Celldex Therapeutics | Initiates: Buy | n/a | $37.01 | - | 1 | Sep 17, 2021 | |
| OMGA Omega Therapeutics | Initiates: Buy | n/a | $2.07 | - | 1 | Aug 24, 2021 | |
| CADL Candel Therapeutics | Initiates: Buy | n/a | $6.25 | - | 1 | Aug 23, 2021 | |
| TCRX TScan Therapeutics | Initiates: Buy | n/a | $5.73 | - | 1 | Aug 10, 2021 | |
| HOWL Werewolf Therapeutics | Initiates: Buy | n/a | $2.06 | - | 1 | May 25, 2021 | |
| LVTX LAVA Therapeutics | Initiates: Buy | n/a | $1.87 | - | 1 | Apr 19, 2021 | |
| EVLO Evelo Biosciences | Upgrades: Buy | n/a | $0.04 | - | 2 | Apr 12, 2021 | |
| ACAD ACADIA Pharmaceuticals | Downgrades: Hold | n/a | $15.84 | - | 2 | Apr 6, 2021 | |
| MCRB Seres Therapeutics | Upgrades: Buy | n/a | $0.70 | - | 1 | Aug 11, 2020 | |
| BLPH Bellerophon Therapeutics | Initiates: Buy | n/a | $0.06 | - | 1 | Aug 11, 2020 | |
| TXMD TherapeuticsMD | Downgrades: Underperform | n/a | $1.66 | - | 1 | Aug 7, 2020 | |
| CORT Corcept Therapeutics | Downgrades: Hold | n/a | $31.56 | - | 1 | Aug 5, 2020 | |
| PTGX Protagonist Therapeutics | Initiates: Buy | n/a | $34.59 | - | 1 | Jul 15, 2020 | |
| LYRA Lyra Therapeutics | Initiates: Buy | n/a | $0.28 | - | 1 | May 26, 2020 |
Structure Therapeutics
Sep 29, 2023
Maintains: Buy
Price Target: $50 → $79
Current: $38.73
Upside: +103.98%
Milestone Pharmaceuticals
Jun 20, 2023
Downgrades: Hold
Price Target: $8 → $4
Current: $1.35
Upside: +196.30%
Veru Inc.
Jun 7, 2023
Upgrades: Hold
Price Target: $1
Current: $0.95
Upside: +4.87%
BioXcel Therapeutics
Mar 10, 2023
Downgrades: Hold
Price Target: $20 → $22
Current: $1.12
Upside: +1,864.29%
Avalo Therapeutics
Feb 8, 2023
Downgrades: Underperform
Price Target: $720
Current: $12.26
Upside: +5,772.76%
Compugen
Feb 8, 2023
Downgrades: Underperform
Price Target: $0.5
Current: $1.69
Upside: -70.41%
UroGen Pharma
Feb 8, 2023
Downgrades: Hold
Price Target: $35 → $10
Current: $15.14
Upside: -33.95%
MEI Pharma
Feb 8, 2023
Downgrades: Underperform
Price Target: $8 → $2
Current: $2.80
Upside: -28.57%
Avadel Pharmaceuticals
Nov 30, 2022
Upgrades: Buy
Price Target: $6.5 → $11
Current: $13.89
Upside: -20.81%
Apellis Pharmaceuticals
Nov 10, 2022
Downgrades: Hold
Price Target: $70 → $40
Current: $34.98
Upside: +14.35%
Harmony Biosciences Holdings
Oct 14, 2022
Upgrades: Buy
Price Target: $57 → $61
Current: $30.00
Upside: +103.33%
Axsome Therapeutics
Sep 30, 2022
Maintains: Buy
Price Target: $92 → $90
Current: $78.93
Upside: +14.03%
Finch Therapeutics Group
Apr 4, 2022
Maintains: Buy
Price Target: $870 → $510
Current: $1.37
Upside: +37,126.28%
Ardelyx
Mar 2, 2022
Upgrades: Buy
Price Target: $1 → $5
Current: $5.28
Upside: -5.30%
Vanda Pharmaceuticals
Feb 25, 2022
Downgrades: Hold
Price Target: $24 → $12
Current: $5.27
Upside: +127.70%
IGM Biosciences
Dec 13, 2021
Maintains: Buy
Price Target: n/a
Current: $6.40
Upside: -
IO Biotech
Nov 30, 2021
Initiates: Buy
Price Target: n/a
Current: $1.18
Upside: -
Celldex Therapeutics
Sep 17, 2021
Initiates: Buy
Price Target: n/a
Current: $37.01
Upside: -
Omega Therapeutics
Aug 24, 2021
Initiates: Buy
Price Target: n/a
Current: $2.07
Upside: -
Candel Therapeutics
Aug 23, 2021
Initiates: Buy
Price Target: n/a
Current: $6.25
Upside: -
TScan Therapeutics
Aug 10, 2021
Initiates: Buy
Price Target: n/a
Current: $5.73
Upside: -
Werewolf Therapeutics
May 25, 2021
Initiates: Buy
Price Target: n/a
Current: $2.06
Upside: -
LAVA Therapeutics
Apr 19, 2021
Initiates: Buy
Price Target: n/a
Current: $1.87
Upside: -
Evelo Biosciences
Apr 12, 2021
Upgrades: Buy
Price Target: n/a
Current: $0.04
Upside: -
ACADIA Pharmaceuticals
Apr 6, 2021
Downgrades: Hold
Price Target: n/a
Current: $15.84
Upside: -
Seres Therapeutics
Aug 11, 2020
Upgrades: Buy
Price Target: n/a
Current: $0.70
Upside: -
Bellerophon Therapeutics
Aug 11, 2020
Initiates: Buy
Price Target: n/a
Current: $0.06
Upside: -
TherapeuticsMD
Aug 7, 2020
Downgrades: Underperform
Price Target: n/a
Current: $1.66
Upside: -
Corcept Therapeutics
Aug 5, 2020
Downgrades: Hold
Price Target: n/a
Current: $31.56
Upside: -
Protagonist Therapeutics
Jul 15, 2020
Initiates: Buy
Price Target: n/a
Current: $34.59
Upside: -
Lyra Therapeutics
May 26, 2020
Initiates: Buy
Price Target: n/a
Current: $0.28
Upside: -